Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 229 (RNA5SP229) is a processed pseudogene that resembles the 5S ribosomal RNA gene but does not encode a functional RNA product. Pseudogenes in general arise from duplication or retrotransposition events and accumulate disabling mutations, so they are typically nonfunctional at the protein or RNA level. Some pseudogenes have been implicated in gene regulation, often as non-coding RNAs, but there is no established function or therapeutic relevance for RNA5SP229 specifically. The term "pseudogene" differentiates it from active 5S rRNA genes, which are components of the ribosome and essential for protein synthesis. RNA5SP229 is annotated as a pseudogene in standard gene databases and carries no known function or relevance as a drug target. Pseudogenes broadly can be transcribed and may play indirect regulatory roles in disease, but these functions are not generalized to all pseudogenes, nor is there specific evidence for disease involvement for RNA5SP229. RNA5SP229 is not a receptor, enzyme, transporter, or recognized therapeutic target. This is a non-protein-coding, non-functional pseudogene, with no evidence supporting its use or consideration as a therapeutic target. It is sometimes considered in large-scale molecular studies (such as cancer transcriptomics) as part of overall pseudogene expression, but individually, RNA5SP229 does not have known clinical or pharmacological significance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 229 (RNA5SP229).